DBV Technologies - 48 Year Dividend Yield History | DBVT

Historical dividend payout and yield for DBV Technologies (DBVT) since 1971. The current TTM dividend payout for DBV Technologies (DBVT) as of February 22, 2019 is $0.00. The current dividend yield for DBV Technologies as of February 22, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.493B $0.013B
DBV Technologies SA is a biopharmaceutical company. It develops products and immunotherapies for the diagnosis and treatment of various food allergies, including milk and peanut. The Company delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin. DBV Technologies SA is headquartered in Bagneux, France.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.316B 12.97
Gilead Sciences (GILD) United States $86.647B 10.87
Bio-Techne Corp (TECH) United States $7.316B 49.29